The PsoTeenQOL - Preliminary Reliability and Validity
NCT03358914 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 233
Last updated 2019-04-24
Summary
This study aims to develop and provide preliminary reliability and validity of a questionnaire to measure Health-related Quality of Life (HRQOL) in adolescents with psoriasis. To the best of our knowledge, this will be the first psoriasis-specific HRQOL instrument for use in adolescent patients. Data will be collected from a Danish population of adolescents with psoriasis (12-17 years), as well as from parents of adolescents with psoriasis, and a group of adolescents without psoriasis.
Conditions
Interventions
- OTHER
-
No intervention
Completion of surveys
Sponsors & Collaborators
-
Herlev and Gentofte Hospital
collaborator OTHER -
LEO Pharma
collaborator INDUSTRY -
University of Aarhus
lead OTHER
Principal Investigators
-
Hilde Randa · University of Aarhus
Eligibility
- Min Age
- 12 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-20
- Primary Completion
- 2019-01-15
- Completion
- 2019-01-31
Countries
- Denmark
Study Locations
More Related Trials
-
A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris
NCT01116895 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis
NCT02387853 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Education Program in Psoriasis
NCT02310204 ·Status: COMPLETED ·Phase: NA
-
Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris
NCT01595997 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cross Sectional Analysis of Healthcare for Psoriasis in 4 European Countries
NCT02668341 ·Status: UNKNOWN
-
A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris
NCT01347255 ·Status: COMPLETED ·Phase: PHASE2
-
LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects
NCT00833872 ·Status: COMPLETED ·Phase: PHASE1
-
LEO 32731 - A Phase I Study in Healthy Subjects
NCT02514694 ·Status: COMPLETED ·Phase: PHASE1
-
A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris
NCT01580488 ·Status: COMPLETED ·Phase: PHASE1
-
A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis Vulgaris
NCT01297166 ·Status: COMPLETED ·Phase: PHASE1
-
LP0058-1005 - A Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy Subjects
NCT02126371 ·Status: COMPLETED ·Phase: PHASE1
-
Improvement of Psoriasis Patients' Adherence to Topical Drugs
NCT04220554 ·Status: COMPLETED ·Phase: NA
-
Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients
NCT01936337 ·Status: COMPLETED ·Phase: PHASE2
-
Psoriasis Inflammation and Systemic Co Morbidities
NCT01170715 ·Status: COMPLETED ·Phase: NA
-
Effect of Long-term Psoriasis on Patients' Life - CORONATE
NCT05555953 ·Status: COMPLETED
-
LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris
NCT02888236 ·Status: COMPLETED ·Phase: PHASE2
-
Patients With Hidradenitis vs Patients With Psoriasis: Psychological Impact
NCT02999698 ·Status: UNKNOWN
-
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
NCT03210961 ·Status: COMPLETED ·Phase: PHASE1
-
Psychotherapy for Patients With Psoriasis: Effects in Quality of Life
NCT02944630 ·Status: UNKNOWN ·Phase: NA
-
Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment
NCT05065762 ·Status: COMPLETED
-
Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris
NCT00817219 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
NCT06801821 ·Status: RECRUITING
-
Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris
NCT03806790 ·Status: COMPLETED ·Phase: PHASE3
-
Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris
NCT02310646 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis
NCT03669757 ·Status: COMPLETED ·Phase: PHASE1